News & Events

Faus Moliner participates in the European Rare Disease Summit 2023 organized by Fundación Bamberg

Jordi Faus takes part in the panel on Innovation and Access to Orphan Drugs

17 Feb 2023

During his intervention Jordi Faus stated that access to orphan drugs is a key issue in the upcoming review of EU pharmaceutical legislation and that...

Jordi Faus focuses his intervention on the incentives for innovation in the upcoming reform of European pharmaceutical law

Faus Moliner

18 Jan 2023

The “Pharmaceutical Strategy for Europe” is a programmatic initiative launched by the Commission in November 2020, which includes a list of actions aimed at promoting...

Lluís Alcover, Joan Carles Bailach and Jordi Faus participated at the Course on Pharmaceutical Law "Biomedicine, Medicines and Public Health" organized by the CEFI Foundation.

Faus Moliner

29 Sep 2022

In the last years, the Course on Pharmaceutical Law organized by Fundación CEFI has become a reference forum for the legal analysis of issues that...

On June 10, 2022 we celebrated the 25th Anniversary of Faus Moliner at the Art Nouveau Site of the Hospital de Sant Pau in Barcelona.

Faus Moliner

1 Jul 2022

The evening began with a dialogue on “The future of medicines in Europe” with the participation of Mª Jesús Lamas, Director of the Spanish Medicines...

Jordi Faus, the best lawyer for pharmaceutical law in Spain according to the Chambers & Partners Guide 2022

Faus Moliner

7 Apr 2022

Chambers and Partners has published the 2022 edition of the Chambers Europe Guide, in which, based on opinions of clients and other lawyers, the leading...

Our founding partner, Jordi Faus, has been appointed Secretary of the International Bar Association (IBA)’s Healthcare & Life Sciences Law Committee

Faus Moliner

14 Feb 2022

The Healthcare and Life Sciences Law Committee is a fast-growing committee with a dynamic and diverse membership across the world, which provides a forum of...

Jordi Faus, Xavier Moliner, Eduard Rodellar y Verónica Carias recognized in the guide The Best Lawyers in Spain

Faus Moliner

23 Nov 2021

The legal guide The Best Lawyers in Spain has recently launched its edition for the year 2022, in which, on the basis of nominations by...

Jordi Faus gives a presentation on the legal challenges raised by nanodrugs

Faus Moliner

20 Oct 2021

Innovations and challenges in nanomedicine have been the subject of a session held within the framework of the 66th Congress of the Spanish Society of...

Faus Moliner participates in the European Rare Disease Summit 2023 organized by Fundación Bamberg

Jordi Faus takes part in the panel on Innovation and Access to Orphan Drugs

Faus Moliner participates in the Conference on the impact of the European Pharmaceutical Strategy in Spain organized by Diariofarma

Jordi Faus focuses his intervention on the incentives for innovation in the upcoming reform of European pharmaceutical law

Faus Moliner participates at the Course on Pharmaceutical Law organized by CEFI

Lluís Alcover, Joan Carles Bailach and Jordi Faus participated at the Course on Pharmaceutical Law "Biomedicine, Medicines and Public Health" organized by the CEFI Foundation.

It´s our anniversary

On June 10, 2022 we celebrated the 25th Anniversary of Faus Moliner at the Art Nouveau Site of the Hospital de Sant Pau in Barcelona.

Faus & Moliner continues to lead the pharmaceutical law in Spain

Jordi Faus, the best lawyer for pharmaceutical law in Spain according to the Chambers & Partners Guide 2022

Jordi Faus appointed Secretary of the International Bar Association (IBA)’s Healthcare & Science Committee

Our founding partner, Jordi Faus, has been appointed Secretary of the International Bar Association (IBA)’s Healthcare & Life Sciences Law Committee

Four lawyers of Faus & Moliner appear in the Best Lawyers Guide 2022 in Spain

Jordi Faus, Xavier Moliner, Eduard Rodellar y Verónica Carias recognized in the guide The Best Lawyers in Spain

Faus & Moliner participates in the 66 Congress of the Spanish Society of Hospital Pharmacy

Jordi Faus gives a presentation on the legal challenges raised by nanodrugs

Awards

Uso de cookies